{
  "trial_id": "NCT02543710",
  "eligibility_criteria": "Inclusion Criteria part 1:\n\nAll patients referred to a participating research centre with suspicion of or confirmed endometrial cancer.\n\nExclusion Criteria part 1:\n\n1. Patients who do not have endometrial cancer\n2. Patients who will or cannot give informed consent (including language barriers)\n3. Patients <18 years of age\n4. Patients who will not get surgical treatment for their endometrial cancer\n\nInclusion criteria part 2:\n\n1. Patients with endometrial or epithelial ovarian cancer who following routine clinical guidelines are offered weekly taxane (paclitaxel) treatment. This will often be a third or fourth line treatment, i.e. patients with advanced disease.\n2. Technical possibility to obtain a new tissue biopsy to determine stathmin level in the tumour recurrence.\n\nExclusion criteria part 2:\n\n1. Patients not suffering from endometrial or epithelial ovarian cancer\n2. Patients <18 years of age\n3. Patients who do not agree to the proposed treatment or will receive (part of) the treatment in a non-participating centre\n4. Patients who cannot or do not want to give informed consent (including language barriers)",
  "sanitised_criteria": "```\nInclusion Criteria part 1:\n- All patients referred to a participating research center with suspicion of or confirmed endometrial cancer.\n\nExclusion Criteria part 1:\n- Patients who do not have endometrial cancer.\n- Patients <18 years of age.\n- Patients who will not get surgical treatment for their endometrial cancer.\n\nInclusion Criteria part 2:\n- Patients with endometrial or epithelial ovarian cancer who, following routine clinical guidelines, are offered weekly taxane (paclitaxel) treatment. This is often a third or fourth line treatment, i.e., patients with advanced disease.\n- Technical possibility to obtain a new tissue biopsy to determine stathmin level in the tumor recurrence.\n\nExclusion Criteria part 2:\n- Patients not suffering from endometrial or epithelial ovarian cancer.\n- Patients <18 years of age.\n- Patients who will receive (part of) the treatment in a non-participating center.\n```",
  "eligibility_groups": [
    "part 1",
    "part 2"
  ]
}